Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
-
Recent Posts
- The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism
- WHA 65 adopted the resolution for way forward on CEWG report on R&D
- Corporations Win Big in Battle Against Investment Regulation
- US and EU Derailing Ten-year Process to Create Health Research & Development Convention
- MSF: Update on debates at World Health Assembly on a possible R&D convention, 23 May 2012
Categories
Tag Archives: Compulsory license
Natco Pharma’s compulsory license application for Cancer Drug- Sorafenib Tosylate
Recently, Natco Pharma, an Indian generic company had applied for Compulsory License (CL) to produce and sell the generic verson of Bayer’s patented cancer drug Sorafenib Tosylate (Brand name-Nexavar).This drug is used in the treatment for liver and kidney cancer. … Continue reading
Middle Income Countries, the new target for Big Pharma
ALCS Morocco & Act Up-Paris call on concerned countries to issue compulsory licencing without delay Casablanca • Paris — A report released by MSF two weeks ago shows that the main pharmaceutical companies that hold most of the patents on … Continue reading
Press: Africa’s Aids patients biggest losers if India/EU drugs deal sails through
Source: The East African, 28.2.2011, by Jeff Otieno Jimmy Gideyi has been on free antiretroviral generic drugs manufactured in India since 2004, when he was confirmed HIV positive. In the past decade, the 56-year-old man has received a constant supply … Continue reading
Posted in EU-India FTA
Tagged Compulsory license, EU, FTA, Generic drug, HIV/Aids, India, Karel de Gucht, Médecins Sans Frontières
Leave a comment
US Cable On Compulsory Licences Part 2
Reference ID Created Released Classification Origin 07BANGKOK598 2007-01-30 23:11 2011-02-06 21:09 UNCLASSIFIED//FOR OFFICIAL USE ONLY Embassy Bangkok VZCZCXRO3066 RR RUEHCHI RUEHDT RUEHHM RUEHNH DE RUEHBK #0598 0302341 ZNR UUUUU ZZH R 302341Z JAN 07 FM AMEMBASSY BANGKOK TO RUEHC/SECSTATE WASHDC … Continue reading
US Cable On Compulsory Licences Part I
Reference ID Created Released Classification Origin 06BANGKOK7335 2006-12-10 05:05 2011-02-06 21:09 CONFIDENTIAL Embassy Bangkok VZCZCXRO1076 PP RUEHCHI RUEHDT RUEHHM RUEHNH DE RUEHBK #7335/01 3440528 ZNY CCCCC ZZH P 100528Z DEC 06 FM AMEMBASSY BANGKOK TO RUEHC/SECSTATE WASHDC PRIORITY 3372 INFO … Continue reading
Press: Natco may seek compulsory licence for Bayer’s cancer drug
Source: Economic Times, 24.1.2011, by Khomba Singh NEW DELHI: Natco Pharma plans to seek a compulsory licence from the government to make Bayer AG’s Nexavar in India, invoking a provision in local laws that allows generic drugmakers to make and … Continue reading
Posted in Compulsory Licensing
Tagged Compulsory license, Generic drug, India, Patent
Leave a comment
